ArticleVirulence2025
The study on the molecular characteristics and variation patterns of the recombinant Muscovy duck parvovirus strain GD-23.
Article in Virulence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of a rapid on-site nucleic acid detection method for new genotype muscovy duck parvovirus based on RPA-CRISPR/Cas12a.Frontiers in veterinary science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As the virus continues to spread, the frequency of contact between different parvovirus strains has increased. In recent years, recombinant Muscovy duck parvovirus (rMDPV) has been widely prevalent in China. In 2023, a strain of rMDPV, designated GD-23, was isolated from Guangdong. After isolation and culture, the entire genome of GD-23 was sequenced. A phylogenetic tree was constructed based on the genomic characteristics of GD-23, and recombination events were analysed. The analysis revealed that the virus underwent two recombination events between different parent strains in the P9 promoter region and part of the VP3 region, with highly consistent start and end breakpoints among rMDPV strains. Using AlphaFold3, the VP3 protein conformation of waterfowl parvoviruses (WPVs) was simulated, and potential receptor interaction regions were predicted based on the structural similarities of capsid proteins among viruses of the same genus. Notably, the rMDPV-GD-23 strain exhibited two identical amino acid mutations at distinct sites, which reduced the overall phosphorylation of the viral capsid. Artificial infection experiments in waterfowl demonstrated that the rMDPV-GD-23 strain was pathogenic to multiple waterfowl hosts. This study provides the first evidence that rMDPV possesses cross-host infection capability, a finding that will aid in identifying key amino acid sites on the capsid surface of WPVs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.